Devon J Shedlock

Devon Shedlock is an accomplished Chief Scientific Officer Of Cell Therapies, showcasing a robust background in the biotechnology sector with expertise in Immunology, Cell Biology, Cell Therapy, Cancer, Molecular Biology, and Flow Cytometry.

Education-wise, Devon Shedlock holds a PhD in Cell and Molecular Biology; Immunology and Microbiology from the University of Pennsylvania School of Medicine, and a BS with Honors in Biology from Ursinus College.

Devon has held various key positions at Poseida Therapeutics, Inc., including Chief Scientific Officer, Senior Vice President, Head of R&D, Vice President of Preclinical Development, Senior Director of Immuno-Oncology, and Director of Immuno-Oncology. Furthermore, his career includes roles as an Adjunct Assistant Professor at the University of Pennsylvania, Associate Director of the T Cell Engineering Lab at Abramson Family Cancer Research Institute, Senior Research Investigator, Senior Postdoctoral Fellow, and Graduate Studies at the University of Pennsylvania School of Medicine.

Additionally, Devon Shedlock has contributed to the field through roles such as Postdoctoral Research Fellow at the National Institutes of Health, Vaccine Research Center, Research Scholar at Rhone-Poulenc Rorer (Sanofi), and through an Undergraduate Research/Internship at Ursinus College.